Literature DB >> 12648942

Enterobacterial adhesins and the case for studying SNPs in bacteria.

Scott J Weissman1, Steve L Moseley, Daniel E Dykhuizen, Evgeni V Sokurenko.   

Abstract

Single-nucleotide polymorphisms (SNPs) in structural genes can have a dramatic effect on the biology of whole organisms, from bacteria and viruses to mammals. Here, we underscore the importance of SNPs in bacterial genes that contribute to the ability of pathogens to cause disease. SNPs that confer an adaptive advantage for bacterial pathogens have been discovered in the genes encoding the FimH and Dr adhesins of Escherichia coli and, most recently, Salmonella enterica sv. Typhimurium FimH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648942     DOI: 10.1016/s0966-842x(03)00010-6

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  17 in total

1.  Insertions, deletions, and single-nucleotide polymorphisms at rare restriction enzyme sites enhance discriminatory power of polymorphic amplified typing sequences, a novel strain typing system for Escherichia coli O157:H7.

Authors:  Indira T Kudva; Robert W Griffin; Megan Murray; Manohar John; Nicole T Perna; Timothy J Barrett; Stephen B Calderwood
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Epidemiologic Investigation of Extra-intestinal pathogenic E. coli (ExPEC) based on PCR phylogenetic group and fimH single nucleotide polymorphisms (SNPs) in China.

Authors:  Kamal Said Abdallah; Yang Cao; Dian-Jun Wei
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

3.  Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms.

Authors:  Wei Zhang; Weihong Qi; Thomas J Albert; Alifiya S Motiwala; David Alland; Eija K Hyytia-Trees; Efrain M Ribot; Patricia I Fields; Thomas S Whittam; Bala Swaminathan
Journal:  Genome Res       Date:  2006-04-10       Impact factor: 9.043

4.  FimY does not interfere with FimZ-FimW interaction during type 1 fimbria production by Salmonella enterica serovar Typhimurium.

Authors:  Sarah A Zeiner; Brett E Dwyer; Steven Clegg
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

Review 5.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55.

Authors:  Sylvie Hudault; O Brad Spiller; B Paul Morgan; Alain L Servin
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Authors:  I Esposito; A de Leone; G Di Gregorio; S Giaquinto; L de Magistris; A Ferrieri; G Riegler
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

8.  Genomic diversity and evolution of Mycobacterium ulcerans revealed by next-generation sequencing.

Authors:  Weihong Qi; Michael Käser; Katharina Röltgen; Dorothy Yeboah-Manu; Gerd Pluschke
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

9.  A Salmonella fim homologue in Citrobacter freundii mediates invasion in vitro and crossing of the blood-brain barrier in the rat pup model.

Authors:  Petra Hess; Artur Altenhöfer; A Salam Khan; Neda Daryab; Kwang Sik Kim; Jörg Hacker; Tobias A Oelschlaeger
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  High-resolution transcriptome maps reveal strain-specific regulatory features of multiple Campylobacter jejuni isolates.

Authors:  Gaurav Dugar; Alexander Herbig; Konrad U Förstner; Nadja Heidrich; Richard Reinhardt; Kay Nieselt; Cynthia M Sharma
Journal:  PLoS Genet       Date:  2013-05-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.